It looks like Big Pharma has met its match.
At the President Elect’s first press conference today, Trump made it very clear he will be keeping an eye on Big Pharma. Here’s what he said, via NPR:
I think a lot of industries are going to be coming back. We have to get our drug industry coming back. Our drug industry has been disastrous. They’re leaving left and right. They supply our drugs, but they don’t make them here. To a large extent. And the other thing we have to do is create a new bidding procedures for the drug industry because they’re getting away with murder.ADVERTISEMENT
Pharma has a lot of lobbies, a lot of lobbyists and a lot of power. And there’s very little bidding on drugs. We’re the largest buyer of drugs in the world, and yet we don’t bid properly. And were going to start bidding and were going to save billions of dollars over a period of time.
Yesterday, Trump appointed Robert Kennedy Jr in a Vaccine Safety role in his administration, which single-handedly became the biggest nightmare to ever hit the Pharmaceutical Industry.
— FinancialNewsNetwork (@FinNewsNet) January 11, 2017
Now the stock market has begun to react:
Big Pharma meets Trump press conference. pic.twitter.com/tq2tThKp7m
— ian bremmer (@ianbremmer) January 11, 2017
Also, the questioning of vaccines has finally seemed to generate some mainstream conversation rather than the normal Big Pharma bully tactics.
I'm against censoring people who ask questions about BigPharma's motivations when they make $25-50 *billion* a year on a product. https://t.co/FSKTr79n2p
— Mike Cernovich ???????? (@Cernovich) January 10, 2017
Donald Trump addressing vaccine safety will bring mainstream media attention to the cause.
It is a new day.